• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Onconetix, Inc. - Common Stock (NQ:ONCO)

    2.089 -1.131 (-35.11%)
    Streaming Delayed Price Updated: 1:59 PM EDT, Mar 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Onconetix, Inc. - Common Stock

    News headline image
    Onconetix Highlights Realbotix’s Role in Ericsson’s World-First 6G Trial Demonstration
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix, Inc. Announces 1-for-5 Reverse Stock Split
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    ONCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Onconetix, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds
    From Onconetix, Inc.
    Via GlobeNewswire
    News headline image
    Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds
    From Onconetix, Inc.
    Via GlobeNewswire
    Nasdaq Stocks Under $1 to Watch Now! VTAK, IVP, ONCO, AKTS, RDHL
    Via AB Newswire
    Topics Supply Chain
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.